Medivation (MDVN) September calls active following Reuters report

Medivation (NASDAQ: MDVN) September 65 and 70 calls are active on total call volume of 3K contracts (1K puts) on Merck (NYSE: MRK) is one of at least five pharmaceutical companies that submitted indications of interest in buying Medivation, reports Reuters. August call option implied volatility is at 55, September is at 36; compared to its 52-week range of 26 to 92.

You May Also Be Interested In

• ExxonMobil (XOM) April weekly option implied volatility into quarter results
• Colgate-Palmolive (CL) April weekly option implied volatility into quarter results
• AbbVie (ABBV) April weekly option implied volatility into quarter results